Abbott Laboratories

Forecast & Rating28 analysts currently cover Abbott Laboratories, with about 75.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $120.20, about 3.5% upside from the current price of $116.13. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 54.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Abbott Laboratories closely still see room for the stock to rise. Data as of Aug 25, 2026; for reference only and not investment advice.